Evaluation of the Antihyperalgesic Effect of Tapentadol in Two Human Experimental Models
Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
MOR-NRI like Tapentadol are expected to reduce signs and symptoms of central sensitisation
besides effectively reducing pain intensity in pain. Human pain surrogate models can serve in
this proof-of-concept study to further elucidate this assumption.
Phase:
Phase 1
Details
Lead Sponsor:
University Hospital Schleswig-Holstein University of Schleswig-Holstein